Every material Form 8-K Avantor has filed with the SEC since October 03, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.
Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
Approved by the Compensation and Human Resources Committee on October 30, 2026
Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% from a year earlier, and returned to year-over-year growth. GAAP diluted EPS was $0.30 versus a loss of $1.04 in the prior-year quarter, which included a $785.0 million goodwill impairment, and the company raised its fiscal 2026 organic revenue growth and free cash flow guidance. Adjusted EPS was flat at $0.22, and adjusted EBITDA fell to $256.9 million from $267.9 million.
Net sales $1,698.3 million, up 4.6% (5.2% organic); VWR Distribution & Services organic growth 5.8%
GAAP diluted EPS $0.30 vs. $(1.04) a year earlier; adjusted EPS $0.22, unchanged
Fiscal 2026 organic revenue growth guidance raised to +0.75% to +1.25% from -0.5% to +0.5%; free cash flow guidance raised to $525 million to $550 million
Free cash flow for the quarter was $156.2 million; total gross debt was $3,699.7 million at September 30, 2026
Avantor appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026, after he served as CFO of CONMED Corporation from January 2018 until March 2026. Steven Eck, who had been Interim CFO since June 24, 2026, will stop serving as interim CFO and remain Senior Vice President and Chief Accounting Officer, so the filing reports a change in the company's principal financial officer rather than a change in reported results.
Todd Garner's annual base salary is $700,000, with a target annual bonus of 80% of base salary and a one-time signing bonus of $150,000.
Garner's initial long-term equity grant has a target value of $1,500,000, split evenly between restricted stock units and stock options.
Garner will be eligible for a long-term incentive target annual grant of $3,000,000 in future years.
Steven Eck will continue as Senior Vice President and Chief Accounting Officer.
Avantor appointed Todd Garner as executive vice president and chief financial officer, effective September 21, 2026. Garner previously served as CFO of CONMED Corporation from January 2018 until March 2026, and Steven Eck will stop serving as interim CFO while remaining chief accounting officer.
Todd Garner, age 57, becomes principal financial officer effective September 21, 2026; he was CFO of CONMED Corporation from January 2018 to March 2026
Garner's employment letter, dated September 17, 2026, sets an annual base salary of $700,000 and a target annual bonus of 80% of base salary
Garner receives a one-time signing bonus of $150,000 and an initial long-term equity grant with a target amount of $1,500,000
Steven Eck ceases to be interim CFO but continues as senior vice president and chief accounting officer
Avantor reported second-quarter 2026 results on July 29, 2026. Net sales rose 0.5% to $1.69 billion, but organic sales fell 0.4%, and net income dropped to $38.1 million from $64.7 million a year earlier. The company raised parts of its fiscal 2026 guidance, including organic revenue growth and adjusted EPS, which signals improved expectations even though profit declined.
Net sales were $1,692.3 million, up 0.5%, with organic sales down 0.4%.
Net income was $38.1 million versus $64.7 million a year earlier; GAAP diluted EPS was $0.06 versus $0.09, and adjusted EPS was $0.21 versus $0.24.
Fiscal 2026 adjusted EPS guidance was raised to $0.80 to $0.83 from $0.77 to $0.83, and organic revenue growth guidance was narrowed to -0.5% to +0.5% from -2.5% to -0.5%.
The company repaid $112.1 million of debt in the quarter, and total gross debt was $3,715.4 million as of June 30, 2026.
Avantor Funding, a wholly owned subsidiary of Avantor, entered into Amendment No. 15 to its credit agreement on July 14, 2026, to obtain a €374,208,296.62 tranche of senior secured euro term loans. The new loans replace and refinance part of existing euro term loans that carried a higher spread, lowering the stated spread from 2.50% to 2.00% and maturing on October 9, 2032. The filing does not state a change to total debt, and a 1.00% prepayment premium applies if the loans are repriced within six months.
Incremental B-7 Euro Term Loans of €374,208,296.62 bear interest at EURIBOR plus 2.00%, down from 2.50% on the loans they replaced
Final maturity is October 9, 2032, the same date as the refinanced loans
A 1.00% prepayment premium applies to certain repricing transactions completed before the six-month anniversary of July 14, 2026
Loans are guaranteed and secured on a pari passu basis with the existing credit facilities
Avantor reported first-quarter 2026 results, with net sales of $1,581.4 million, flat from a year earlier, but a 4.1% organic decline after a positive currency effect of 4.1%. Net income fell to $43.3 million from $64.5 million, and diluted GAAP EPS dropped to $0.06 from $0.09, so shareholders saw lower profit on flat revenue. The company reaffirmed its fiscal 2026 guidance from February 11, 2026.
Net sales were $1,581.4 million, flat year over year; organic sales declined 4.1%.
Net income was $43.3 million versus $64.5 million; diluted GAAP EPS was $0.06 versus $0.09.
Adjusted EPS was $0.17 versus $0.23; adjusted EBITDA was $219.4 million versus $269.5 million.
Avantor reaffirmed fiscal 2026 guidance first given on February 11, 2026.
Avantor said Ludovic Brellier, formerly President of Cytiva's Hardware Solutions business at Danaher, will join as Executive Vice President, Bioscience & Medtech Products (BMP) and Chief Transformation Officer effective May 1, 2026. He will lead the BMP business and the Revival Management Office, which drives transformation initiatives across the enterprise. The filing also says current BMP segment head Benoit Gourdier is moving to a segment integration role and is expected to leave no later than December 31, 2026.
Ludovic Brellier starts May 1, 2026 as EVP, BMP and Chief Transformation Officer
Brellier will lead the Revival Management Office, overseeing enterprise transformation initiatives
Benoit Gourdier moves to a segment integration role and is expected to depart by December 31, 2026
The announcement was made in a press release dated April 23, 2026
Avantor said Executive Vice President and CFO R. Brent Jones will leave the company on or before June 24, 2026, to join a company outside the life sciences industry. Chief Accounting Officer Steve Eck will serve as interim CFO while the company searches for a permanent CFO, and the company reaffirmed its fiscal 2026 guidance.
Jones notified the company on March 26, 2026 of his resignation; his employment agreement requires 90 days' notice unless waived.
Eck, 50, has been Senior Vice President and Chief Accounting Officer since 2019 and will keep those roles while serving as interim CFO.
Eck will receive $45,000 per month as interim CFO and a one-time restricted stock unit award valued at $250,000 that vests over three years.
Avantor reaffirmed the fiscal 2026 financial guidance it gave on its fourth quarter 2025 earnings call on February 11, 2026.
Avantor reported fourth-quarter and full-year 2025 results on February 11, 2026, with sales down and a full-year GAAP net loss driven by a $785 million goodwill impairment. The company also said it is realigning its reporting into two segments starting in the first quarter of 2026, with recast historical data provided for investors.
Q4 2025 net sales were $1.66 billion, down 1.4% from a year earlier; Q4 GAAP diluted EPS was $0.08 versus $0.73 a year earlier, and adjusted EPS was $0.22 versus $0.27.
Full-year 2025 net sales were $6.55 billion, down 3.4%, with a net loss of $530 million versus net income of $712 million in 2024.
Full-year 2025 included an impairment charge of $785 million tied to the goodwill of the Distribution reporting unit; adjusted EPS was $0.90 versus $0.99 in 2024.
Two reportable segments, VWR Distribution & Services and Bioscience & Medtech Products, take effect in Q1 2026; the first 10-Q under the new structure is for the quarter ending March 31, 2026.
Avantor's Board elected Simon Dingemans as a director effective January 2, 2026, filling the seat left by Jonathan Peacock's resignation effective December 31, 2025. The filing describes Dingemans's prior roles at The Carlyle Group, GSK and Goldman Sachs and sets his standard non-employee director pay, so shareholders gain a new board member but no change in financial results or operations is reported.
Simon Dingemans elected director by the Board on December 17, 2025, effective January 2, 2026, with term ending at the 2026 Annual Meeting
Filled vacancy created by Jonathan Peacock's resignation from the Board, effective December 31, 2025
Annual cash retainer of $95,000 plus restricted stock units with a grant date fair value of $210,000, vesting May 6, 2026
Previously served as CFO of GSK plc from 2011 to 2019; the Board determined he meets NYSE independence standards
Avantor's board elected Sanjeev Mehra, co-founder and managing partner of Periphas Capital, as a director on December 4, 2025. His initial term runs until the 2026 Annual Meeting of Stockholders, and the filing says he meets NYSE and Exchange Act independence standards.
Mehra is 66 and was a Goldman Sachs partner from 1998 to 2017; he also serves on the board of OPENLANE, Inc.
Non-employee director pay includes a $95,000 annual cash retainer, prorated for 2025, and restricted stock units with a $210,000 grant date fair value.
The restricted stock units are scheduled to vest in full one year from the grant date, subject to continued board service.
The filing reports no arrangements with other persons for his selection and no material related-party interest.
Avantor named Mary Blenn Executive Vice President and Chief Operating Officer, a newly created role, effective immediately. She will lead manufacturing and supply chain operations and report to President and CEO Emmanuel Ligner. The filing also sets out her pay package, including a $500,000 base salary and a $5,000,000 target equity grant.
Mary Blenn appointed EVP and Chief Operating Officer, effective immediately; role is newly created
Base salary of $500,000 with a target annual bonus of 75% of base salary
Initial equity grant with target grant date fair value of $5,000,000, with $400,000 awarded at her start date and the remainder in February 2026
The filing also amends the education description of CEO Emmanuel Ligner and adds committee appointments for director Gregory Lucier effective November 6, 2025
Avantor reported third-quarter 2025 results with net sales of $1.62 billion, down 5.3% from a year earlier, and a net loss of $712 million after a $785 million non-cash goodwill impairment tied to its Distribution unit. The company also announced a new $500 million share repurchase authorization, which it said reflects confidence in its cash generation.
Net sales were $1.62 billion, down 5.3%, with an organic decline of 4.7%
Net loss was $712 million, or $1.04 per diluted share, including the $785 million goodwill impairment; adjusted EPS was $0.22 versus $0.26 a year earlier
Operating cash flow was $207 million and free cash flow was $172 million for the quarter
Board authorized a $500 million share repurchase program
Avantor's borrowing subsidiary signed an amendment on October 9, 2025 that sets up $1.4 billion of revolving credit and new euro term loans of €400 million and €550 million, with maturities extending to 2030 and 2032. The new facilities will repay the company's existing A/R facility, which had about $208 million outstanding, and the remaining €250 million of senior first lien notes, which were redeemed on October 10, 2025. The filing reflects a debt refinancing and does not report earnings or guidance.
Revolving credit commitments total $1.4 billion, with maturity extended to October 9, 2030.
New €400 million Euro Term A Loan matures October 9, 2030; new €550 million Euro Term B-6 Loan matures October 9, 2032.
PNC-led accounts receivable facility of up to $300 million was repaid and terminated on October 9, 2025.
Remaining €250 million of 2.625% notes due 2025 were redeemed on October 10, 2025 at 100% of principal.
Avantor said Chairman Jonathan Peacock will step down as chairman and from the Board and Nominating and Governance Committee on December 31, 2025, and that he did not resign over any disagreement with the company. Board member Gregory L. Summe will become chairman on January 1, 2026, a planned leadership transition rather than a change in reported results.
Jonathan Peacock informed Avantor on October 10, 2025 of his decision to step down.
Peacock's last day as chairman and director is expected to be December 31, 2025.
Gregory L. Summe, a current Board member, will serve as chairman from January 1, 2026.
The filing states the departure was not due to any disagreement on operations, policies or practices.
Avantor's board elected Gregory Lucier, Executive Chairman and CEO of Corza Medical, as a director effective October 3, 2025, with his term running until the 2026 Annual Meeting of Stockholders. The filing describes this as a board addition with standard non-employee director compensation, and it reports no financial results.
Gregory Lucier elected to the board on October 1, 2025, effective October 3, 2025
Annual cash retainer of $95,000, prorated for 2025, plus restricted stock units valued at $210,000 at grant
Restricted stock units vest in full one year from grant date, subject to continued board service
Board determined Lucier meets New York Stock Exchange independence standards
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Avantor filing is on SEC EDGAR ↗. 8-K briefs of other companies →